Dados B3Stocks › SYNE3 PT

Consumo Cíclico

SYNE3 — SYN PROP & TECH S.A.

CNPJ 08.801.621/0001-86 · listed classes: SYNE3, CCPR3 · CVM code 21040

11.1P/E
1.1P/B
4.9EV/EBITDA
6.7%FCF yield
7.4%ROE 2025
5.7%ROIC 2025
P/E, P/B and EV/EBITDA priced at the session of 2026-03-26 (R$ 4.70), the first one after the 2025 filing became public on 2026-03-26 — point-in-time, not the 31 December price. acoes_escala_milhares

The full history, year by year

The arrow opens the path from the figure down to the line in the regulator's file. A cell with ! carries a caveat; a dash is a withheld figure — hover for the reason. Nothing is hidden.

indicator2010201120122013201420152016201720182019202020212022202320242025
ROE 20.0%!23.1%26.8%22.4%13.3%2.4%-1.8%14.9%-0.1%2.2%2.9%78.1%-3.6%-0.7%42.2%7.4%
ROIC 17.4%!18.6%17.4%10.2%6.8%4.3%3.9%!11.0%3.9%5.0%4.7%40.1%2.7%!2.9%!24.6%5.7%
ROA 8.8%!9.7%10.4%7.7%4.0%1.1%0.3%5.3%1.4%2.2%2.5%28.6%-0.7%0.1%18.5%2.8%
Gross margin 70.0%62.6%55.8%69.8%66.2%66.0%61.1%58.1%58.2%65.3%63.0%72.2%43.7%55.3%42.2%53.1%
EBIT margin 61.0%55.5%46.4%70.9%64.0%67.6%68.3%105.6%!43.5%57.6%50.2%70.9%30.1%40.6%61.5%47.4%
Net margin 44.6%41.4%35.3%59.3%39.0%13.6%3.4%49.8%10.1%20.6%26.3%60.9%-6.9%1.3%48.6%22.8%
Revenue growth (1y) 27.7%56.8%-13.6%18.5%0.6%9.6%5.9%9.7%-3.9%3.3%374.2%-79.4%-10.5%219.7%-75.9%
Revenue growth (5y CAGR) 9.7%6.4%3.7%8.7%4.3%4.8%40.5%1.2%-2.8%23.6%-7.6%
Net debt/EBITDA 1.53x1.86x2.81x5.75x7.56x6.72x6.41x2.54x5.31x3.51x3.44x0.50x3.49x2.77x0.43x1.20x
Current ratio 4.39x1.05x3.26x1.29x2.33x1.38x1.13x1.39x1.39x3.88x2.57x2.78x4.84x5.28x5.21x1.30x

The current year, quarter by quarter

As the company filed it in its interim report. The fourth quarter does not exist on its own in that filing — the closed year comes in the annual one, and we do not derive a Q4, so that a figure we computed never sits beside the figures the company reported. Filed on is the date the report became public, and the price is taken from it.

quarterrevenueprofitnet marginP/E TTMP/Bfiled on
2024T1!112.412.911.4%120.80.912024-05-10
2024T2!1,081.4566.452.4%3.40.802024-08-14
2024T3!86.036.442.4%2.60.822024-11-14
2025T1!83.823.928.5%1.60.822025-05-15
2025T2!74.419.626.4%9.01.022025-08-14
2025T3!87.025.329.0%6.31.022025-11-13
2026T1!82.326.231.8%8.50.812026-05-14
2026T2!81.914.117.3%10.50.822026-08-13

Full series, every quarter: GET /empresas/SYNE3/trimestres

Dividends per year

yearper sharepayments
2025R$ 3.03974
2024R$ 6.55122
2022R$ 0.52411
2021R$ 8.26782
2020R$ 0.93262
2018R$ 1.00281
2017R$ 2.88911
2016R$ 0.04641

Piotroski F-Score 5/9 (2025) — what each criterion means.

Restated filings for this company

The regulator overwrites the old version; we keep both. Figures in R$ millions: first filing on the left, restatement on the right.

fiscal yearaccountfirst filingrestated
2021DMPL 5.070.01,665.3
2019BPP 2.02.011,868.21,473.2
2012BPP 2.03721.11,038.5
2012DMPL 5.07721.11,038.5
2012BPP 2.03.0992.6410.0
2010BPA 1.01.010.1302.3
2010BPA 1.01.02302.30.0
2012BPA 11,858.62,143.3

This company appears in

Other companies in Consumer Cyclical

109 more with a page, same CVM sector — a classification of the regulator's, not ours.

Take this into your code

Everything on this page is also JSON: GET /empresas/SYNE3/indicadores. WEGE3 is open for testing without a key; for the rest, create a free key (200 calls/day, no card).

Price coverage: 3,517 sessions, 2010-01-04 → 2026-09-04 · methodology · how we verify

Numbers on this page are live. Data version 2026-09-01-supressao-declarada · page generated 2026-09-08 11:12 UTC. If this does not match /saude, you are reading a cached copy.